Prana Biotechnology - Stock Price History | ATHE

Historical daily share price chart and data for Prana Biotechnology since 2023 adjusted for splits. The latest closing stock price for Prana Biotechnology as of February 03, 2023 is 3.95.
  • The all-time high Prana Biotechnology stock closing price was 739.80 on January 30, 2014.
  • The Prana Biotechnology 52-week high stock price is 10.50, which is 165.8% above the current share price.
  • The Prana Biotechnology 52-week low stock price is 2.90, which is 26.6% below the current share price.
  • The average Prana Biotechnology stock price for the last 52 weeks is 5.82.
For more information on how our historical price data is adjusted see the Stock Price Adjustment Guide.
Prana Biotechnology Historical Annual Stock Price Data
Year Average Stock Price Year Open Year High Year Low Year Close Annual % Change
2022 6.2547 7.6505 11.1000 2.9510 3.4820 -51.64%
2021 13.7565 14.0000 21.8000 7.2000 7.2000 -46.27%
2020 12.4736 7.7000 34.3000 3.5920 13.4000 71.79%
2019 13.4791 19.2000 21.0000 7.8000 7.8000 -39.06%
2018 21.0775 32.5000 32.5000 11.2990 12.8000 -58.97%
2017 26.7688 17.5000 36.0000 17.5000 31.2000 91.41%
2016 37.1840 42.7680 59.8000 16.3000 16.3000 -62.48%
2015 67.1138 100.2000 100.2000 42.6000 43.4400 -55.85%
2014 223.6546 421.8000 739.8000 88.8000 98.4000 -76.60%
2013 201.2068 138.0000 445.2000 126.0000 420.6000 218.64%
2012 110.8734 87.6000 177.6000 85.8000 132.0000 49.66%
2011 105.4483 77.4000 220.8000 74.4000 88.2000 17.60%
2010 80.7853 79.2000 144.6000 66.0000 75.0000 -5.30%
2009 96.4174 139.2060 172.8000 60.0000 79.2000 -30.53%
2008 221.1463 248.4000 335.4000 97.8000 114.0000 -52.50%
2007 170.1170 187.8000 240.0060 126.6000 240.0000 31.58%
2006 133.8935 95.3400 251.4000 82.2000 182.4000 94.87%
2005 127.4004 244.8000 280.8000 64.2000 93.6000 -61.58%
2004 273.0931 296.4000 526.8000 204.6000 243.6000 -17.98%
2003 268.6500 299.4000 330.0000 211.8000 297.0000 0.00%
Sector Industry Market Cap Revenue
Medical Medical - Biomedical and Genetics $0.016B $0.003B
Prana Biotechnology was established to commercialize research into Alzheimer's disease and other major age-related degenerative disorders. Their mission is to develop diagnostic and therapeutic drugs to treat the central disease pathways that cause degeneration of the brain as the aging process progresses. Prana's technology has emerged from its researchers at prominent international institutions such as Massachusetts General Hospital at Harvard Medical School and the University of Melbourne.
Stock Name Country Market Cap PE Ratio
Bristol Myers Squibb (BMY) United States $158.293B 9.67
GSK (GSK) United Kingdom $71.300B 9.41
Bio-Rad Laboratories (BIO.B) United States $12.069B 28.64
QIAGEN (QGEN) Netherlands $11.249B 19.20
Ginkgo Bioworks Holdings (DNA) United States $3.996B 0.00
Myovant Sciences (MYOV) United Kingdom $2.614B 0.00
Arcus Biosciences (RCUS) United States $1.485B 22.29
Biohaven (BHVN) United States $1.240B 0.00
Emergent Biosolutions (EBS) United States $0.697B 5.48
ADC Therapeutics SA (ADCT) Switzerland $0.356B 0.00
Enzo Biochem (ENZ) United States $0.070B 0.00
Ambrx Biopharma (AMAM) United States $0.070B 0.00
SQZ Biotechnologies (SQZ) United States $0.024B 0.00
Gelesis Holdings (GLS) United States $0.024B 0.00